Today, several clinical observations, like electrocardiography (ECG), systolic blood pressure and blood laboratory parameters, such as cardiac troponin I (CTn I), creatine kinase-myocardial band (CK-MB), high-sensitivity C-reactive protein (hs-CRP) and brain natriuretic peptides (BNPs) are used for myocardial infarction (MI) (Koenig, 2013; Shrivastava et al., 2015). This evidence concerns the gene TNNI3 and myocardial infarction.